Xcout Intel
ExpreS2ion Biotech Holding
ExpreS2ion Biotech Holding is a clinical-stage biotechnology company that develops innovative immunotherapies and vaccines to treat cancer and prevent infectious diseases. Utilizing its proprietary ExpreS2 protein expression system and a virus-like particle delivery platform, the company creates candidates such as its lead HER2 cancer immunotherapy, ES2B-C001.
Subscribe to see ExpreS2ion Biotech Holding’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ExpreS2ion Biotech Holding at a glance
ExpreS2ion Biotech Holding is a health care company headquartered in Sweden. Xcout tracks 7 named people at ExpreS2ion Biotech Holding, including Bent U. Frandsen (Chief Executive Officer).
ExpreS2ion Biotech Holding leadership
- Bent U. FrandsenChief Executive Officer
- Keith AlexanderChief Financial Officer
- Dr. Max M. SøgaardChief Scientific Officer
- Dr. Martin Roland JensenChairman of the Board
- Dr. Karin GarreBoard Member
- Jakob KnudsenBoard Member
1 more named person on record for ExpreS2ion Biotech Holding, with roles, board committees and tenure — see the full roster →
ExpreS2ion Biotech Holding competitors
A few of ExpreS2ion Biotech Holding's closest competitors — see the full list of competitors and alternatives →
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
Symphogen, part of the Servier Group, operates as an Antibody Center of Excellence focusing on oncology and immuno-oncology. The company utilizes an antibody discovery and research platform to develop monoclonal antibody therapeutics aimed at improving treatments for cancer patients.
Combined Therapeutics is a biotechnology company that develops next-generation mRNA vaccines and immunotherapies for infectious diseases and oncology. The company utilizes a proprietary mRNA platform featuring microRNA binding sequences to target therapeutic protein expression in specific tissues while protecting vital organs from off-target effects.
Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop therapeutic products.
T3 Pharmaceuticals AG is a biotechnology company that develops a proprietary technology platform utilizing bacteria to deliver targeted therapies. The company focuses on advancing a pipeline of Immuno-Oncology products designed to treat cancer patients.
Get ExpreS2ion Biotech Holding's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ExpreS2ion Biotech Holding in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access